Kepivance and oedema Patient Reports February 12, 2012

Kepivance Side Effects Report #4977749-5
Kepivance side effect was reported by a Health Professional from FRANCE on Apr 10, 2006. Male patient, 51 years of age, was diagnosed with pre-existing disease and was treated with Kepivance. After drug was administered, patient experienced the following side effects: burning sensation, erythema, face oedema, inflammation, mouth ulceration, skin discolouration, stomatitis. Kepivance dosage: unknown. During the same period patient was treated with ALKERAN, VELCADE, SERESTA, MORPHINE SULPHATE, SKENAN, ACYCLOVIR, RANITIDINE, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #4957922-2
Kepivance side effect was reported by a Health Professional from FRANCE on Mar 20, 2006. Female patient, 51 years of age, weighting 213.8 lb, was diagnosed with peripheral blood stem cell apheresis and was treated with Kepivance. After drug was administered, patient experienced the following side effects: back pain , dysgeusia, headache , oedema, oedema mucosal, pruritus, rash papular, skin discolouration, stomatitis. Kepivance dosage: unknown. During the same period patient was treated with VELCADE, VFEND, GELOX, FUNGIZONE, HEPARIN, RANIPLEX, ACYCLOVIR, ALKERAN. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #4955292-7
Kepivance side effect was reported by a Health Professional from FRANCE on Mar 17, 2006. Female patient, 60 years of age, weighting 101.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: dysgeusia, erythema, glossitis, odynophagia, oedema, oral mucosal discolouration, oral pain, pruritus, skin discolouration. Kepivance dosage: unknown. During the same period patient was treated with RIVOTRIL, IMOVANE, MOPRAL, CELIPROLOL, IDARAC, GELOX, FUNGIZONE, HEPARIN. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #4949408-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: fluid retention, lung infiltration, mucosal inflammation, oedema, pneumonia , pulmonary congestion, weight increased. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.


Kepivance Side Effects Report #4966049-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia , pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #4993498-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia , pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #4994851-2
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia , pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Kepivance Side Effects Report #5019950-0
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia , pulmonary congestion. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.